Literature DB >> 29315655

Polymorphism of HLA class I and class II alleles in influenza A(H1N1)pdm09 virus infected population of Assam, Northeast India.

Mousumi Dutta1, Prafulla Dutta1, Subhash Medhi2, Biswajyoti Borkakoty1, Dipankar Biswas1.   

Abstract

Human leucocyte antigen (HLA) represents one of the most highly polymorphic systems which plays a central role in the immune response. Genetic polymorphism of HLA in influenza A(H1N1)pdm09 infected population may be an important factor in disease progression and severity that needs further probing. In this study, a total of 110 Influenza like illness patients were recruited from the population of Assam, Northeast India, from which 35 cases infected by A(H1N1)pdm09 viruses and 35 controls were typed for HLA-A, B and DRB1 locus by PCR-SSP method. A total of seven alleles of HLA-A, 16 alleles of HLA-B, and 11 alleles of HLA-DRB1 locus were identified. The most common alleles within each locus in cases were HLA-A*11 (85.71%, P = 0.046), HLA-B*35 (25%, P = 0.0001), and HLA-DRB1*15 (49.35%,  P = 0.133) as compared to the controls, HLA-A*11 (40.82%), HLA-B*35 (0.00%), and HLA-DRB1*15 (67.53%). The frequency of HLA-A*11 and HLA-B*35 were significantly higher in cases as compared to the controls. In DRB1 locus, HLA-DRB1*10 was significantly higher in cases (20.78%, P = 0.005) than that of controls (0.00%). Whereas, HLA-DRB1*15 showed a higher frequency in controls than in cases. In addition, HLA-DRB3*01 (P = 0.053), DRB4*01 (P = 1.000), and DRB5*01(P = 0.591) were also identified along with HLA-DRB1 haplotype. From this preliminary study, it is suspected that there may be a role of HLA-A*11, HLA-B*35 and HLA-DRB1*10 in conferring susceptibility to influenza A(H1N1)pdm09 infection in the study population. A larger extended study on HLA polymorphism may explain the association between HLA and influenza A(H1N1)pdm09 infection and provide insights for HLA restricted peptide based vaccines.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  HLA; immune responses; influenza virus; pandemic

Mesh:

Substances:

Year:  2018        PMID: 29315655     DOI: 10.1002/jmv.25018

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  18 in total

Review 1.  Unclear Issues Regarding COVID-19.

Authors:  Aycan Yuksel; Dilek Karadogan; Canan Gunduz Gurkan; Fatma Tokgoz Akyil; Zehra Nur Toreyin; Feride Marim; Huseyin Arikan; Tugba Sismanlar Eyuboglu; Nagehan Emiralioglu; Irem Serifoglu; Elif Develi; Selman Celik; Umran Ozden Sertcelik; Tugba Ramasli Gursoy; Mehmet Fatih Elversli; Asli Oncel; Berrin Er; Ali Firincioglulari; Fatma Esra Gunaydin; Hilal Ozakinci; Neslihan Ozcelik; Dorina Esendagli; Asena Aydin; Neslihan Kose; Merve Ercelik; Pinar Yildiz Gulhan; Ethem Yildiz; Ilim Irmak; Bilge Yilmaz Kara; Selcuk Gurz; Fatma Gulsum Karakas; Metin Akgun
Journal:  Eurasian J Med       Date:  2020-06

Review 2.  A Scoping Insight on Potential Prophylactics, Vaccines and Therapeutic Weaponry for the Ongoing Novel Coronavirus (COVID-19) Pandemic- A Comprehensive Review.

Authors:  Priyanka Dash; Subhashree Mohapatra; Sayantan Ghosh; Bismita Nayak
Journal:  Front Pharmacol       Date:  2021-02-26       Impact factor: 5.810

3.  Genetic polymorphisms associated with susceptibility to COVID-19 disease and severity: A systematic review and meta-analysis.

Authors:  Cristine Dieter; Letícia de Almeida Brondani; Cristiane Bauermann Leitão; Fernando Gerchman; Natália Emerim Lemos; Daisy Crispim
Journal:  PLoS One       Date:  2022-07-06       Impact factor: 3.752

4.  Cell-Mediated Immune Responses to COVID-19 Infection.

Authors:  Amélie Guihot; Elena Litvinova; Brigitte Autran; Patrice Debré; Vincent Vieillard
Journal:  Front Immunol       Date:  2020-07-03       Impact factor: 7.561

5.  Polymorphisms in Processing and Antigen Presentation-Related Genes and Their Association with Host Susceptibility to Influenza A/H1N1 2009 Pandemic in a Mexican Mestizo Population.

Authors:  Marco Antonio Ponce-Gallegos; Aseneth Ruiz-Celis; Enrique Ambrocio-Ortiz; Gloria Pérez-Rubio; Alejandra Ramírez-Venegas; Nora E Bautista-Félix; Ramcés Falfán-Valencia
Journal:  Viruses       Date:  2020-10-29       Impact factor: 5.048

Review 6.  Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview.

Authors:  Leila Mohamed Khosroshahi; Mohsen Rokni; Tahmineh Mokhtari; Farshid Noorbakhsh
Journal:  Int Immunopharmacol       Date:  2021-01-05       Impact factor: 5.714

Review 7.  An overview of Betacoronaviruses-associated severe respiratory syndromes, focusing on sex-type-specific immune responses.

Authors:  Golbarg Rahimi; Bahareh Rahimi; Mohammad Panahi; Shadi Abkhiz; Neda Saraygord-Afshari; Morteza Milani; Effat Alizadeh
Journal:  Int Immunopharmacol       Date:  2021-01-10       Impact factor: 5.714

Review 8.  COVID-19: the role of excessive cytokine release and potential ACE2 down-regulation in promoting hypercoagulable state associated with severe illness.

Authors:  Fenghe Du; Bao Liu; Shuyang Zhang
Journal:  J Thromb Thrombolysis       Date:  2021-02       Impact factor: 2.300

9.  COVID-19 infection: the perspectives on immune responses.

Authors:  Yufang Shi; Ying Wang; Changshun Shao; Jianan Huang; Jianhe Gan; Xiaoping Huang; Enrico Bucci; Mauro Piacentini; Giuseppe Ippolito; Gerry Melino
Journal:  Cell Death Differ       Date:  2020-03-23       Impact factor: 15.828

10.  Common genetic variation in humans impacts in vitro susceptibility to SARS-CoV-2 infection.

Authors:  Kristina Dobrindt; Daisy A Hoagland; Carina Seah; Bibi Kassim; Callan P O'Shea; Marina Iskhakova; Michael B Fernando; P J Michael Deans; Samuel K Powell; Ben Javidfar; Aleta Murphy; Cyril Peter; Rasmus Møeller; Meilin Fernandez Garcia; Masaki Kimura; Kentaro Iwasawa; John Crary; Darrell N Kotton; Takanori Takebe; Laura M Huckins; Benjamin R tenOever; Schahram Akbarian; Kristen J Brennand
Journal:  bioRxiv       Date:  2020-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.